In conclusion, the complement components C3, C5, C3AR1, and C5AR1 demonstrated a context-dependent association with tumor immune evasion, prognosis, and therapy response with high implicative value in melanoma, colorectal, brain, breast, stomach, and renal cancer. Here, C3AR1 is linked to neoplasm.